Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 41.39B | 39.34B | 33.51B | 36.80B | 29.55B | 28.26B |
Gross Profit | 8.96B | 8.83B | 8.01B | 8.46B | 5.97B | 6.09B |
EBITDA | 6.67B | 6.81B | 5.79B | 6.72B | 4.39B | 4.91B |
Net Income | 3.44B | 3.57B | 3.05B | 5.86B | 2.13B | 1.86B |
Balance Sheet | ||||||
Total Assets | 198.54B | 201.93B | 193.40B | 175.51B | 169.42B | 148.52B |
Cash, Cash Equivalents and Short-Term Investments | 5.85B | 4.91B | 5.09B | 6.09B | 4.95B | 4.72B |
Total Debt | 135.26B | 140.28B | 135.74B | 119.57B | 120.48B | 100.04B |
Total Liabilities | 156.08B | 159.30B | 153.26B | 137.63B | 135.95B | 116.49B |
Stockholders Equity | 41.90B | 42.49B | 39.78B | 37.55B | 33.34B | 31.89B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -3.33B | -14.93B | -1.41B | -19.89B | -1.28B |
Operating Cash Flow | 0.00 | -3.25B | -14.87B | -1.30B | -19.88B | -1.27B |
Investing Cash Flow | 0.00 | -334.00M | -903.00M | 3.62B | -81.00M | -2.00M |
Financing Cash Flow | 0.00 | 3.41B | 14.73B | -1.16B | 20.19B | 665.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥27.20B | 7.57 | 5.68% | 17.40% | 17.97% | ||
74 Outperform | ¥837.64B | 9.77 | 3.87% | 1.67% | 18.46% | ||
73 Outperform | ¥11.92B | 7.93 | 1.86% | 2.12% | -6.76% | ||
71 Outperform | ¥32.45B | 7.39 | 2.40% | -22.59% | 26.96% | ||
71 Outperform | ¥10.12B | 7.93 | 4.28% | 6.95% | 4.92% | ||
70 Outperform | ¥354.70B | 7.81 | 3.91% | -4.25% | -4.22% | ||
67 Neutral | €8.31B | 20.67 | 6.46% | 2.74% | 1.85% | -38.87% |